What does this research mean for the field?

Ischemia-free liver transplantation (IFLT) significantly decreases intraoperative hemorrhage and blood product transfusion compared to conventional liver transplantation (CLT). Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

What question did this study set out to answer?

The study aims to evaluate the effects of ischemia-free liver transplantation (IFLT) on coagulation function in liver transplant patients.

February 26, 2026International Journal of SurgeryOpen Access

Ischemia-free liver transplantation protects coagulation function via the HNF4α–coagulation factor axis: a post hoc analysis from the IFLT-DBD randomized controlled trial

View Full Paper

Ask AI

Bookmark

Authors

YDYuqi DongSun Yat-sen University XCXiaoxiang ChenSun Yat-sen University WXWei XiongNational Iranian Oil Company (Iran)

Discussion

Member takes

Implication

Post hoc analysis demonstrates reduced blood loss in liver transplantation, suggesting improved coagulation management.

Key Points

The study aims to evaluate the effects of ischemia-free liver transplantation (IFLT) on coagulation function in liver transplant patients.
Performed a post hoc analysis of 65 liver transplant patients from the IFLT-DBD trial
Evaluated blood loss, transfusion requirements, and intraoperative coagulation tests
Conducted bulk transcriptome analysis and real-time PCR on liver tissue specimens
Assessed HNF4α expression using Western blotting
Total blood loss was significantly lower in IFLT compared to conventional transplantation (1765.0 mL vs. 2600.0 mL, P < 0.001)
The IFLT group required fewer blood product transfusions (RBC: 4 units vs. 7.25 units, FFP: 600 mL vs. 600 mL, PLT: 6 vs. 13, P values < 0.031)
Transcriptome analysis revealed higher HNF4α expression in IFLT group tissues
Real-time PCR showed increased mRNA levels of HNF4α, factor II, and V in IFLT group

Cite This Study

Dong et al. (2026) studied this question.

synapsesocial.com/papers/699fe41d95ddcd3a253e8522 https://doi.org/10.1097/js9.0000000000004987

View Full Paper

Ask AI

Bookmark

Ischemia-free liver transplantation protects coagulation function via the HNF4α–coagulation factor axis: a post hoc analysis from the IFLT-DBD randomized controlled trial

Discussion

Member takes

Implication

Key Points

Cite This Study

Ischemia-free liver transplantation protects coagulation function via the HNF4α–coagulation factor axis: a post hoc analysis from the IFLT-DBD randomized controlled trial

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider